Directory › Siegfried

Siegfried — Grafton

Grafton, Wisconsin, United States · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Siegfried
Name(s) in FDA data
Siegfried Grafton, Inc.
FEI number(s)
3001655239 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Grafton, Wisconsin, United States 53024
Records matched
6 FDA inspections
Most recent FDA inspection in dataset
14 Aug 2024 — NAI

Capabilities (from the company's website)

  • Highly potent (HPAPI)
    …y expertise, and regulatory-compliant quality systems — all with the capability to manage highly potent and controlled substances. The Acceleration Hub provides end-to-end life cycle management…
  • Formulation & process development
    …broad portfolio of technologies and capabilities, including phase-appropriate preclinical process development, advanced filtration technologies, CMC sections o…
  • Controlled substances
    …egulatory-compliant quality systems — all with the capability to manage highly potent and controlled substances. The Acceleration Hub provides end-to-end life cycle management with services from precl…

Taken from the part of the company's network/locations page that describes this site. Source: https://www.siegfried.ch/company/locations/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 14 Aug 2024
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3001655239, inspection ID 1234253)

  2. 15 Jul 2016
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 3001655239, inspection ID 981372)

  3. 04 Apr 2013
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3001655239, inspection ID 826305)

  4. 10 Jun 2011
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3001655239, inspection ID 732143)

  5. 20 Sep 2010
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3001655239, inspection ID 683854)

  6. 14 Dec 2009
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3001655239, inspection ID 633328)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.